Amplia Therapeutics Appoints Christopher Burns as CEO and MD
Amplia Therapeutics (ATX) appoints Christopher Burns as CEO and Managing Director, effective from December 5
...
Amplia Therapeutics Granted $2.1 million R&D cash flow loan
Amplia Therapeutics (ATX) has been granted a $2.1 million Research and Development (R&D) cash flow...
